Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Danino

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Biodesign Research|July 3, 2026
Toward development of soil-derived <i>Bacillus</i> isolates as lung cancer cytotoxic agentsDhruba Deb, Filippo Liguori, Bentley M Shuster, et al.
Nature Biomedical Engineering|August 15, 2025
Engineered bacteria launch and control an oncolytic virusZakary S Singer, Jonathan Pabón, Hsinyen Huang, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Engineered bacteria launch and control an oncolytic virusZakary S Singer, Jonathan Pabón, Hsinyen Huang, et al.
Nature Biotechnology|April 1, 2025
The emerging landscape of engineered bacteria cancer therapiesEdward R Ballister, Alexander Michels, Rosa L Vincent, et al.
Iscience|April 8, 2019
Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coliAlex J H Fedorec, Tanel Ozdemir, Anjali Doshi, et al.
Nature|July 21, 2016
Synchronized cycles of bacterial lysis for in vivo deliveryM Omar Din, Tal Danino, Arthur Prindle, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug"Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto, et al.
Science Immunology|October 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanismsFangda Li, Zaofeng Yang, Thomas M Savage, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapyMathieu Rouanne, Noah Chen, Dylan L Mariuzza, et al.
Science Advances|March 8, 2023
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunityThomas M Savage, Rosa L Vincent, Sarah S Rae, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Biodesign Research|July 3, 2026
Toward development of soil-derived <i>Bacillus</i> isolates as lung cancer cytotoxic agentsDhruba Deb, Filippo Liguori, Bentley M Shuster, et al.
Nature Biomedical Engineering|August 15, 2025
Engineered bacteria launch and control an oncolytic virusZakary S Singer, Jonathan Pabón, Hsinyen Huang, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
Engineered bacteria launch and control an oncolytic virusZakary S Singer, Jonathan Pabón, Hsinyen Huang, et al.
Nature Biotechnology|April 1, 2025
The emerging landscape of engineered bacteria cancer therapiesEdward R Ballister, Alexander Michels, Rosa L Vincent, et al.
Iscience|April 8, 2019
Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coliAlex J H Fedorec, Tanel Ozdemir, Anjali Doshi, et al.
Nature|July 21, 2016
Synchronized cycles of bacterial lysis for in vivo deliveryM Omar Din, Tal Danino, Arthur Prindle, et al.
Biorxiv : the Preprint Server for Biology|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug"Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto, et al.
Science Immunology|October 18, 2024
Programmable bacteria synergize with PD-1 blockade to overcome cancer cell-intrinsic immune resistance mechanismsFangda Li, Zaofeng Yang, Thomas M Savage, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapyMathieu Rouanne, Noah Chen, Dylan L Mariuzza, et al.
Science Advances|March 8, 2023
Chemokines expressed by engineered bacteria recruit and orchestrate antitumor immunityThomas M Savage, Rosa L Vincent, Sarah S Rae, et al.
Pageof 6